SHR-0302

Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

SHR0302 and Steroid As First Line Therapy for Chronic GVHD

To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis

Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata

A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis

Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis

Study on the Bioavailability of SHR0302 in Healthy Subjects

Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment

Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients

A Phase II Study in Patients With Alopecia Areata

Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects

Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients

First-in-Human Single Ascending Dose of SHR0302